Posted on August 7, 2020 by Sitemaster
A report this week in Urologic Oncology has confirmed the importance of PSA doubling times in understanding risk for prostate cancer progression among men with non-metastatic, castration-resistant prostate cancer (nmCRPC). … READ MORE …
Filed under: Uncategorized | Tagged: castration-resistant, doubling, mCRPC, metastasis, nmCRPC, non-metastatic, PSA, survival | 1 Comment »
Posted on September 20, 2019 by Sitemaster
A new paper in Clinical Genitourinary Cancer has provided us with some more detailed information about risk for metastasis in men with recurrent prostate cancer after first-line surgery. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: doubling, Gleason, metastasis, PSA, risk, score, time | 14 Comments »
Posted on December 15, 2014 by Sitemaster
A small study from one hospital in Norway has suggested that PSA doubling times after surgery may predict the value of salvage radiation therapy alone as a second line form of therapy. … READ MORE …
Filed under: Uncategorized | Tagged: doubling, invasion, outcome, PSA, radiation, salvage, seminal vesicle | 1 Comment »
Posted on December 21, 2012 by Sitemaster
A new commentary on the Health Imaging web site discusses recent Italian data on the potential use of [11C]choline PET/CT scanning in early re-staging and salvage treatment of men with a rising PSA after radical prostatectomy. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: choline-11, doubling, PET/CT, PSA, re-staging, scan | 8 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 